US Stock MarketDetailed Quotes
POAI Predictive Oncology
- 1.4300
- -0.3300-18.75%
Close May 31 16:00 ET
- 1.4300
- 0.00000.00%
Post 19:59 ET
5.87MMarket Cap-390P/E (TTM)
1.7811High1.2900Low431.15KVolume1.7100Open1.7600Pre Close685.85KTurnover11.86%Turnover RatioLossP/E (Static)4.10MShares7.120052wk High1.45P/B5.20MFloat Cap1.120052wk Low--Dividend TTM3.64MShs Float1910.0000Historical High--Div YieldTTM27.90%Amplitude1.1200Historical Low1.5900Avg Price1Lot Size
Predictive Oncology Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 0.34%-3.42M | -6.62%-13.19M | 4.72%-3.08M | -14.66%-3.1M | -7.20%-3.57M | -10.80%-3.43M | -1.33%-12.37M | 13.60%-3.23M | 7.82%-2.71M | -51.21%-3.33M |
| Net income from continuing operations | -23.29%-4.22M | 45.67%-13.98M | 56.10%-3.48M | 22.07%-3.16M | 62.24%-3.92M | -1.52%-3.42M | -30.93%-25.74M | -2.06%-7.92M | 25.35%-4.06M | -303.71%-10.39M |
| Operating gains losses | -1,918.00%-1.01K | 88.59%-11.55K | -116.74%-733 | 66.11%-3.46K | 92.29%-7.31K | 92.94%-50 | 36.31%-101.3K | 104.56%4.38K | -688.65%-10.22K | -406.56%-94.75K |
| Depreciation and amortization | -31.65%162.57K | -43.70%739.32K | -52.41%158.34K | -50.75%162.99K | -44.72%180.14K | -26.50%237.85K | -2.03%1.31M | -10.04%332.69K | 2.98%330.94K | -0.40%325.84K |
| Other non cash items | -96.40%734 | -42.30%301.47K | -15.06%95.77K | -8.05%111.26K | -17.78%74.04K | -89.73%20.4K | -55.19%522.44K | -24.97%112.75K | 0.78%120.99K | 0.32%90.05K |
| Change In working capital | 342.48%640.53K | -145.87%-397.56K | -79.95%139.61K | -123.34%-212.33K | 87.74%-60.68K | -8.04%-264.16K | 172.56%866.69K | 552.64%696.45K | 220.22%909.77K | -528.42%-495.02K |
| -Change in receivables | -462.87%-175.75K | -110.87%-2.5K | 3,353.07%211.06K | -1,074.48%-113.91K | -107.31%-148.09K | -45.72%48.43K | 210.74%23K | -164.38%-6.49K | 114.86%11.69K | -204.42%-71.43K |
| -Change in inventory | 4.89%52.66K | -49.23%-63.88K | -186.01%-54.39K | -142.27%-46.29K | 29.20%-13.41K | 173.83%50.2K | 56.38%-42.81K | 514.36%63.23K | 76.16%-19.11K | 24.27%-18.94K |
| -Change in prepaid assets | 218.64%108.78K | -155.31%-43.38K | -16.36%98.99K | -260.70%-189.46K | 139.10%138.77K | -146.51%-91.68K | 140.35%78.43K | -0.72%118.35K | 133.36%117.9K | -472.52%-354.95K |
| -Change in payables and accrued expense | 314.28%660.57K | -99.91%724 | -113.01%-54.65K | -54.14%390.27K | -258.44%-26.61K | 37.88%-308.28K | 193.15%791.67K | 545.14%420.13K | 772.82%850.96K | 108.33%16.8K |
| -Change in other current liabilities | ---1.95K | 121.48%5.46K | 199.56%5.46K | --0 | --0 | --0 | 70.38%-25.42K | -104.61%-5.48K | 86.02%-16.25K | -159.32%-41.37K |
| -Change in other working capital | -110.15%-3.77K | -802.99%-293.98K | -162.66%-66.87K | -613.87%-252.94K | 54.87%-11.34K | 959.31%37.17K | -23.34%41.82K | 337.29%106.71K | -1,869.54%-35.43K | -16,854.67%-25.13K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 0.34%-3.42M | -6.62%-13.19M | 4.72%-3.08M | -14.66%-3.1M | -7.20%-3.57M | -10.80%-3.43M | -1.33%-12.37M | 13.60%-3.23M | 7.82%-2.71M | -51.21%-3.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 93.50%-3.03K | 36.44%-302.37K | 111.47%7.3K | 97.27%-3.92K | -37.69%-259.1K | 41.87%-46.64K | 95.52%-475.7K | 99.35%-63.6K | 22.94%-143.68K | 21.81%-188.17K |
| Net PPE purchase and sale | 87.56%-3.03K | 34.18%-276.35K | 112.59%7.3K | 96.94%-3.92K | -35.70%-255.36K | 46.32%-24.37K | 53.88%-419.87K | 70.42%-57.95K | -23.85%-128.34K | 14.16%-188.17K |
| Net intangibles purchase and sale | --0 | 53.39%-26.02K | 99.98%-1 | --0 | ---3.74K | 36.08%-22.27K | -7.58%-55.83K | -373.03%-5.65K | 44.89%-15.34K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 93.50%-3.03K | 36.44%-302.37K | 111.47%7.3K | 97.27%-3.92K | -37.69%-259.1K | 41.87%-46.64K | 95.52%-475.7K | 99.35%-63.6K | 22.94%-143.68K | 21.81%-188.17K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -112.37K | -97.78%148.9K | -371.19%-111.32K | 6,560.30%260.22K | 0 | 0 | -86.66%6.72M | 36.98%-23.63K | -127.25%-4.03K | -66.76%6.66M |
| Net issuance payments of debt | ---112.37K | --150.41K | ---109.81K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | ---- | -100.02%-1.51K | 93.61%-1.51K | --0 | ---- | ---- | -86.88%6.72M | -127.16%-23.63K | -5.75%-4.03K | -66.76%6.66M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---112.37K | -97.78%148.9K | -371.19%-111.32K | 6,560.30%260.22K | --0 | --0 | -86.66%6.72M | 36.98%-23.63K | -127.25%-4.03K | -66.76%6.66M |
| Net cash flow | ||||||||||
| Beginning cash position | -60.45%8.73M | -21.74%22.07M | -53.08%11.92M | -47.74%14.76M | -25.95%18.6M | -21.74%22.07M | 4,057.64%28.2M | -39.21%25.39M | -37.06%28.25M | -8.00%25.12M |
| Current changes in cash | -1.64%-3.53M | -117.63%-13.34M | 4.09%-3.19M | 0.25%-2.85M | -222.32%-3.83M | -12.55%-3.47M | -122.28%-6.13M | 75.52%-3.32M | 8.16%-2.86M | -82.18%3.13M |
| End cash Position | -72.05%5.2M | -60.45%8.73M | -60.45%8.73M | -53.08%11.92M | -47.74%14.76M | -25.95%18.6M | -21.74%22.07M | -21.74%22.07M | -39.21%25.39M | -37.06%28.25M |
| Free cash flow | 1.59%-3.42M | -5.02%-13.49M | 6.78%-3.08M | -9.02%-3.11M | -8.83%-3.83M | -9.47%-3.47M | 2.47%-12.85M | 16.30%-3.3M | 7.09%-2.85M | -44.03%-3.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg